Abhay Joshi
2021
Compensation breakdown
| Non-Equity Incentive Plan | $154,081 |
|---|---|
| Option Awards | $634,014 |
| Salary | $519,754 |
| Stock Awards | $1,267,172 |
| Other | $11,738 |
| Total | $2,586,759 |
Joshi received $1.3M in stock awards, accounting for 49% of the total pay in 2021.
Joshi also received $154.1K in non-equity incentive plan, $634K in option awards, $519.8K in salary and $11.7K in other compensation.
Rankings
In 2021, Abhay Joshi's compensation ranked 5,029th out of 12,415 executives tracked by ExecPay. In other words, Joshi earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,029 out of 12,415 | 60th |
Division Manufacturing | 2,118 out of 5,508 | 62nd |
Major group Chemicals And Allied Products | 905 out of 2,378 | 62nd |
Industry group Drugs | 810 out of 2,099 | 61st |
Industry Pharmaceutical Preparations | 579 out of 1,549 | 63rd |
Pay ratio
| Abhay Joshi's Pay | $2,586,759 |
|---|---|
| Median Employee's Pay | $248,326 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Abhay Joshi was $2,586,759.
The annual total compensation of the median employee at Revance Therapeutics was $248,326.
The ratio of Abhay Joshi's pay to the pay of median employee was therefore 10 to one.
Joshi's colleagues
We found four more compensation records of executives who worked with Abhay Joshi at Revance Therapeutics in 2021.
News
March 24, 2022
March 11, 2021
March 26, 2020
March 25, 2019